Text from here

Information

Back issues
7.27.2020
【Press Release】The Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine, collaborating with the Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, developed the world's first drug delivery system that suppresses accumulation in peripheral tissues and delivers drugs only to brain tissues
An articles on this subject were published in the media.
7.27.2020
【Information】A paper published in PNAS on July 23, which was first authored by Dr. Daniel Gonzalez-Carter of iCONM Kataoka-Kina Lab, was selected as “Editor's Choice” by an US medical media “BioWorld Science”. Daniel answered to the media interview to explain the world's first method in which the administered drug does not accumulate in peripheral tissues but is selectively taken into the brain.
7.20.2020
【Information】 Dr. Satoshi Uchida, Visiting Scientist (Project Assistant Professor, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo) will be introduced on TV Tokyo "Stairs of Quest". Please take a look.

Program name: TV Tokyo "Stairs of Quest" #42
Broadcast date: Thursday, July 23, 2020 at 22:54 ~
Title: "Aiming for a panacea with nano medicine" / Dr. Satoshi Uchida (Visiting Scientist, Innovation Center of Nanomedicine / Project Assistant Professor, The University of Tokyo / MD)
7.19,20.2020
【Coverage】An interview article of Prof. Kataoka about Smart Nanomachine ® and mRNA was published in Tokyo Shimbun, Chunichi Shimbun.
  • "Deeper understanding of Corona!" Development and design at high speed | Tokyo Shimbun / Morning edition , Chunichi Shimbun / Morning edition
7.17.2020
【Information】 Dr.Satoshi Uchida, Visiting Scientist (Project Assistant Professor, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo) was interviewed by German media Ruptly TV about Smart Nanomachine®.
6.26.2020
【Press conference】For the first time in the world, Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine has succeeded in controlling the clearance of gene therapy drugs at the liver sinusoidal wall by developing a reagent for the selective and transient coating of the liver sinusoidal walls. This was collaborative research with the National Institute for Quantum Science and Technology and Department of Bioengineering, Graduate School of Engineering, The University of Tokyo. A press conference was held.
This research result was published in "Science Advances"
An articles on this subject were published in the media.
Click here for the media coverage list
6.26.2020
【Coverage】 The research group of Dr. Akira Matsumoto, Associate Professor and Dr. Yuji Miyahara, Professor, Institute of Biomaterials, Tokyo Medical and Dental University (COINS Theme 4) developed a closed-loop artificial pancreas device, which was combined with glucose-responsive gel and hollow fiber for hemodialysis.
  • Fully synthetic artificial pancreas device, Tokyo Medical and Dental University, Nagoya University, etc. developed | The Science News
6.18.2020
【Coverage】ICONM and AccuRna Inc. were introduced in the special feature of Nikkei Beyond Health.
6.17.2020
【Coverage】On 4/2 An article about the press release announced jointly with Graduate School of Engineering, The University of Tokyo was published in the Yakuji Nippo.
Compound development for control of hepatitis -replace cell growth factor The University of Tokyo/Kawasaki institute of Industrial Promotion Innovation Center of NanoMedicine research group | Yakuji Nippo
6.11.2020
【Activity Report】14th COINS General meeting was held on June 11.
Click here for details
6.4.2020
【Press conference】The Innovation Center of Nanomedicine, Kawasaki Institute of Industrial Promotion started collaborative research with the Tokyo Metropolitan Institute of Medical Science on April 1st 2020. It aims to create technology for the rapid development of mRNA vaccine integrated with an adjuvant function to be prepared for the recurrence of the new coronavirus (covid-19), and /or further mutated species of “coronavirus”.
An articles on this subject were published in the media.
Click here for the media coverage list
6.2.2020
【Coverage】5/22 The contents of the COINS seminar # 52 held online was published in "Nikkei Beyond Health".
5.29.2020
【Coverage】5/22 The contents of the COINS seminar # 52 held online was published in "Iyakutsushin".
5.22.2020
【Activity Report】May 22 (Fri.), COINS Seminar #52 was held online.
Speaker: Prof. Nobuhiro NISHIYAMA / Professor, Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology
Title: "Development of Medical NanoMachines Based on Fine Design of Functional Polymers”
Click here for details
5.20.2020
【Press conference】Dr. Kazunori Kataoka, Director General, iCONM, Dr. Kouhei Tsumoto, Professor, University of Tokyo, Dr. Yasutaka Anraku, Visiting Scientist, iCONM / Project Associate Professor, The University of Tokyo, Dr. Takanori Yokota, Professor, Tokyo Medical and Dental University and their research group designed and synthesized smart nanomachine® that efficiently deliver antibody drugs into the brain and succeeded in demonstrating the suppression of amyloid β aggregation in brain parenchyma at low doses in Alzheimer-type dementia model mice, and a joint press conference was held.
This research result was published in "ACS Nano"
An articles on this subject were published in the media.
Click here for the media coverage list
5.12.2020
【Press Release】Dr. Kazunori Kataoka (Principal Research Scientist/Laboratory Head)'s joint research group of Innovation Center of NanoMedicine (iCONM) including Dr. Takuya Miyazaki from Kanagawa Institute of Industrial Science and Technology (KISTEC), Dr. Horacio Cabral (Associate Professor), Dr. Takeshi Nagamatsu (Associate Professor) Dr. Kensuke Suzuki from The University of Tokyo, have developed nanomedicine for chemotherapy during pregnancy. With this nanomedicine, we can treat intractable diseases like preeclampsia and preterm birth without drug distribution in fetus.
This press release received the Publicity Award from the Public Relations Committee of the Polymer Society of Japan.
5.8.2020
【Information】We will hold the COINS Seminar #52 online.
May 22 (Fri.) 15:00-16:30
Speaker: Prof. Nobuhiro NISHIYAMA / Professor, Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology
Title: "Development of Medical NanoMachines Based on Fine Design of Functional Polymers”
Holding method: ZOOM * web conferencing software.
Click here for details
*Registration is now closed.
5.1.2020
【Coverage】 The article that AnGes Inc., which has a laboratory in iCONM, has started joint development of a new coronavirus vaccine with Professor Morishita of Osaka University was published.
5.1.2020
【Award】Dr. Hiroyasu Takemoto (Assistant Professor, Tokyo Institute of Technology), a visiting scientist, COINS Theme 5, received the 2019 Award for Encouragement of Research in Polymer Science, the Society of Polymer Science, Japan.
  • Title: Development of the Functional Polymers that Recognize Biosignals and the Application for Drug Delivery System
4.30.2020
【Coverage】An interview article with Dr. Keiji Itaka (Professor, Tokyo Medical and Dental University), who is the leader of COINS Theme 3, has been carried.
  • 【Commentary Q&A】 Let's learn about RNA vaccine that the world will hooked on "| NewsPicks
4.28.2020
【Coverage】An article about smart NanoMachines and in-body hospitals was published in Deutsche Well, a state news agency in Germany.
4.22.2020
【Activity Report】An inner-communication event was held using a web conference system
Click here for the details.
4.8.2020
【Coverage】 Dr. Keiji Itaka, COINS Theme 3 leader Professor, (Professor, Tokyo Medical and Dental University), commented on the Covid-19 vaccine of Moderna, Inc. which is a well-known venture in nucleic acid medicine.
4.2.2020
【Press Release】Dr. Kazuko Toh (Research scientist)'s collaborative research group of Innovation Center of NanoMedicine (iCONM) including Dr. Ryosuke Ueki (Assistant Professor), Dr. Satoshi Uchida (Project Associate Professor), Dr. Horacio Cabral (Associate Professor) , Dr. Shinsuke Sando (Professor) from the Graduate School of Engineering, The University of Tokyo have developed a cell growth factor replacement compound that shows high biological activity in living organisms.
We can expect that this should lead to significant cost reduction and safety improvement of regenerative medicine in the future. The results were published in the US science journal "Science Advances".
4.1.2020
【Coverage】 The collaboration between the project of AccuRna, Inc. and Braizon Therapeutics, Inc. and the academic research of iCONM/COINS on nucleic acid medicines using smart nanomachines is covered.
  • Challenge of Industry-government-academia for nucleic acid drug creation (6) Development of new polymer-based DDS for practical use: The effort centering on venture companies based on industry-academia collaboration | Pharm Tech Japan
4.1.2020
【Coverage】The article about Dr. Theofilus A. Tockary, iCONM research scientist appeared in RikeLab.
RikeLab is a site that supports scientists and science course students as a research institute that thinks about the ideal work style for a scientist is.
Comment by Dr. Theofilus: I hope this article will help young scientists!

Click here for the research outcome of Dr. Theofilus and his group

About COINS

COINS (Center of Open Innovation Network for Smart Health) is a research center of an entirely new idea for developing "products and services that changes the future" by anticipating social needs in the future and integrating cutting-edge technologies, human resources and ideas from universities and private companies in and outside Japan.

COINS is an initiative under the Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI STREAM) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.

Page Top